We hypothesize that the paradoxical activity of a BRAF inhibitor could be leveraged in the setting of acute radiation dermatitis, where temporary hyperproliferation is desirable to repopulate the epidermal keratinocytes and restore the skin barrier. The gene discussed is BRAF; the disease is radiodermatitis.